US56600D1072
US56600D1072
Maravai LifeSciences Holdings,
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 185.743.000 | 259.185.000 | 28.3% |
| Cost of Revenue | 151.753.000 | 150.876.000 | 0.6% |
| Gross Profit | 33.990.000 | 108.309.000 | 68.6% |
| 162.520.000 | 180.992.000 | 10.2% | |
| Operating Income | -128.530.000 | -72.683.000 | 76.8% |
| Pretax Income | -234.974.000 | -261.482.000 | 10.1% |
| Net Income Common Stockholders | -130.773.000 | -144.846.000 | 9.7% |
| -- | -- | -- | |
| -- | -- | -- |